Visceral obesity, hepatic lipase activity, and dyslipidemia in type 1 diabetes

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 7, 2003, Pages 3379-3384

  Sibley, Shalamar D ^a   Palmer, Jerry P ^b   Hirsch, Irl B ^b   Brunzell, John D ^b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIVER TRIACYLGLYCEROL LIPASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; ATHEROSCLEROSIS; BODY FAT; BODY MASS; CONTROLLED STUDY; CORRELATION FUNCTION; DIABETIC OBESITY; DYSLIPIDEMIA; ENZYME ACTIVITY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIVER METABOLISM; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL;

ADIPOSE TISSUE; ADOLESCENT; ADULT; BODY WEIGHT; COHORT STUDIES; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERLIPIDEMIAS; LIPASE; LIVER; MALE; MIDDLE AGED; OBESITY; REGRESSION ANALYSIS; SEX FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0037622750     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2002-021693     Document Type: Article

References (35)

1. Haarbo J, Hassager C, Riis BJ, Christiansen C 1989 Relation of body fat distribution to serum lipids and lipoproteins in elderly women. Atherosclerosis 80:57-62
2. Mykkanen L, Laakso M, Pyorala K 1992 Association of obesity and distribution of obesity with glucose intolerance and cardiovascular risk factors in the elderly. Int J Obes Relat Metab Disord 16:695-704
3. Ostlund RE, States M, Kohrt WM 1990 The ratio of waist-to-hip circumference, plasma insulin level, and glucose tolerance as independent predictors of the HDL2 cholesterol level in older adults. N Engl J Med 322:229-234
4. Walton C, Lees B, Crook D, Worthington M, Godsland I, Stevenson J 1995 Body fat distribution, rather than overall adiposity, influences serum lipids and lipoproteins in healthy men. Am J Med 99:459-464
5. Fujimoto W, Abbate S, Kahn S, Hokanson J, Brunzell J 1994 The visceral adiposity syndrome in Japanese-American men. Obese Res 2:364-371
6. Despres JP, Ferland M, Moorjani S, Nadeau A, Tremblay A, Lupien PJ, Theriault G, Bouchard C 1989 Role of hepatic-TG lipase activity in the association between intra-abdominal fat and plasma HDL cholesterol in obese women. Arteriosclerosis 9:485-492
7. Carr MC, Hokanson JE, Zambon A, Deeb SS, Barrett PH, Purnell JQ, Brunzell JD 2001 The contribution of intraabdominal fat to gender differences in hepatic lipase activity and low/high density lipoprotein heterogeneity. J Clin Endocrinol Metab 86:2831-2837
8. Cominacini L, Garbin U, Davoli A, Campagnola M, DeSantis A, Pasini C, Pastorino AM, Bosello O 1993 High-density lipoprotein cholesterol concentrations and postheparin hepatic and lipoprotein lipases in obesity: relationships with plasma insulin levels. Ann Nutr Metab 37:175-184
9. Katzel LI, Coon PJ, Busby MJ, Gottlieb SO, Krauss RM, Goldberg AP 1992 Reduced HDL2 cholesterol subspecies and elevated postheparin hepatic lipase activity in older men with abdominal obesity and asymptomatic myocardial ischemia. Arteriosder Thromb 12:814-823
10. Ronnemaa T, Mamiemi J, Savolainen MJ, Kesaniemi YA, Ehnholm C, Bouchard C, Koskenvuo M 1998 Serum lipids, lipoproteins, and lipid metabolizing enzymes in identical twins discordant for obesity. J Clin Endocrinol Metab 83:2792-2799
11. Purnell JQ, Kahn SE, Albers JJ, Nevin DN, Brunzell JD, Schwartz RS 2000 Effect of weight loss with reduction of intra-abdominal fat on lipid metabolism in older men. J Clin Endocrinol Metab 85:977-982
12. Abrams JJ, Ginsberg H, Grundy SM 1982 Metabolism of cholesterol and plasma triglygerides in nonketotic diabetes mellitus. Diabetes 31:903-910
13. Agboola-Abu CF, Ohwovoriole AE, Akinlade KS 2000 The effect of glycaemic control on the prevalence and pattern of dyslipidemia in Nigerian patients with newly diagnosed non insulin dependent diabetes mellitus. West Afr J Med 19:27-33
14. Kissebah AH, Alfarsi S, Evans DJ, Adams PW 1982 Integrated regulation of very low density lipoprotein TG and apolipoprotein-B kinetics in non-insulin dependent diabetes mellitus. Diabetes 31:217-225
15. Phillips C, Murugasu G, Owens D, Collins P, Johnson A, Tomkin GH 1999 Improved metabolic control reduces the number of postprandial apolipoprotein B-48 containing particles in type 2 diabetes. Atherosclerosis 148:283-291
16. Berglund G, Hellstrom A, Ljungman S, Hartford M, Wikstrand J 1987 The relationship between obesity-related metabolic factors and vascular changes in early hypertension. J Hum Hypertens 1:25-30
17. Van Gaal LF, Vansant GA, De Leeuw HH 1989 Upper body adiposity and the risk for atherosclerosis. J Am Coll Nutr 8:504-514
18. Kannel WB, Cupples LA, Ramaswami R, Stokes 3rd J, Kreger BE, Higgins M 1991 Regional obesity and risk of cardiovascular disease; the Framingham Study. J Clin Epidemiol 44:183-190
19. Purnell JQ, Hokanson JE, Marcovina SM, Steffes MW, Cleary PA, Brunzell JD 1998 Effect of excessive weight-gain with intensive therapy of type 1 diabetes on lipid levels and blood pressure: results from the DCCT. Diabetes Control and Complications Trial [published erratum appears in JAMA 1998 280:1484]. JAMA 280:140-146
20. DCCT Research Group 1986 The Diabetes Control and Complications Group: The Diabetes Control and Complications Trial: design and methodologic considerations for the feasibility phase. Diabetes 35:530-545
21. 1980 Department of Health and Human Services: the prevalence study. In: The lipid research clinics population studies data book. Vol 1, NIH Pub. no. 80-1527. Washington, DC: US Govt. Printing Office; 1-115
22. Metropolitan Life Insurance Company 1983 Metropolitan height and weight tables. Stat Bull Metrop Insur Co 64:2-9
23. DCCT Research Group 1999 Epidemiology of diabetes interventions and complications: design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort. Diabetes Care 22:99-111
24. Shuman WP, Morris LL, Leonetti DL, Wahl PW, Moceri VM, Moss AA, Fujimoto WY 1986 Abnormal body fat distribution detected by computed tomography in diabetic men. Invest Radiol 21:483-487
25. Fujimoto WY, Newell-Morris LL, Grote M, Bergstrom RW, Shuman WP 1991 Visceral fat obesity and morbidity: NIDDM and atherogenic risk in Japanese American men and women. Int J Obes 15:(Suppl 2):41-44
26. Marcovina SM, Albers JJ, Dati F, Ledue TB, Ritchie RF 1991 International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B. Clin Chem 37:1676-1682
27. Auwerx JH, Marzetta CA, Hokanson JE, Brunzell JD 1989 Large buoyant LDL-like particles in hepatic lipase deficiency. Arteriosclerosis 9:319-325
28. Lindgren FT, Jensen LC, Wills RD, Freeman NK 1969 Flotation rates, molecular weights and hydrated densities of the low density lipoproteins. Lipids 4:337-344
29. Lindgren F, Jensen L, Hatch F 1972 The isolation and quantitative analysis of serum lipoproteins. In: Nelson GJ, ed. Blood lipids and lipoproteins: quantitation, composition and metabolism. New York: Wiley; 181-274
30. Iverius PH, Brunzell JD 1985 Human adipose tissue lipoprotein lipase: changes with feeding in relation to postheparin plasma enzyme. Am J Physiol 249:E107-E114
31. Anderson AJ, Sobocinski KA, Freedman DS 1988 Body fat distribution, plasma lipids, and lipoproteins. Arteriosclerosis 8:88-94
32. DCCT Research Group 1993 The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986
33. DCCT Research Group 1995 Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial. Am J Cardiol 75:894-903
34. Erbey JR, Kuller LH, Becker DJ, Orchard TJ 1998 The association between a family history of type 2 diabetes and coronary artery disease in a type 1 diabetes population. Diabetes Care 21:610-614
35. Williams KV, Erbey JR, Becker D, Orchard TJ 1999 Improved glycemic control reduces the impact of weight-gain on cardiovascular risk factors in type 1 diabetes. The Epidemiology of Diabetes Complications Study. Diabetes Care 22:1084-1091